Novo Nordisk's Wegovy and Eli Lilly's Mounjaro have demonstrated remarkable commercial success, with Wegovy sales reaching 9.6 billion DKK in Q3 2023, driving significant share price increases for both companies.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.